Skip to main content
Log in

Double-hit myeloma with IGH/MYC and IGH/CCND1 translocations

  • Letter to the Editor
  • Published:
Annals of Hematology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

References

  1. Avet-Loiseau H, Attal M, Moreau P, Charbonnel C, Garban F, Hulin C et al (2007) Genetic abnormalities and survival in multiple myeloma: the experience of the Intergroupe Francophone du Myélome. Blood 109:3489–3495

    Article  PubMed  CAS  Google Scholar 

  2. Stewart AK, Bergsagel PL, Greipp PR, Dispenzieri A, Gertz MA, Hayman SR et al (2007) A practical guide to defining high-risk myeloma for clinical trials, patient counseling and choice of therapy. Leukemia 21:529–534

    Article  PubMed  CAS  Google Scholar 

  3. Soverini S, Cavo M, Cellini C, Terragna C, Zamagni E, Ruggeri D et al (2003) Cyclin D1 overexpression is a favorable prognostic variable for newly diagnosed multiple myeloma patients treated with high-dose chemotherapy and single or double autologous transplantation. Blood 102:1588–1594

    Article  PubMed  CAS  Google Scholar 

  4. Moreau P, Facon T, Leleu X, Morineau N, Huyghe P, Harousseau JL et al (2002) Recurrent 14q32 translocations determine the prognosis of multiple myeloma, especially in patients receiving intensive chemotherapy. Blood 100:1579–1583

    Article  PubMed  CAS  Google Scholar 

  5. Fonseca R, Bergsagel PL, Drach J, Shaughnessy J, Gutierrez N, Stewart AK et al (2009) International Myeloma Working Group molecular classification of multiple myeloma: spotlight review. Leukemia 23:2210–2221

    Article  PubMed  CAS  Google Scholar 

  6. Avet-Loiseau H, Gerson F, Magrangeas F, Minvielle S, Harousseau JL, Bataille R (2001) Rearrangements of the c-myc oncogene are present in 15 % of primary human multiple myeloma tumors. Blood 98:3082–3086

    Article  PubMed  CAS  Google Scholar 

  7. Aukema SM, Siebert R, Schuuring E, van Imhoff GW, Kluin-Nelemans HC, Boerma EJ et al (2011) Double-hit B-cell lymphomas. Blood 117:2319–2331

    Article  PubMed  CAS  Google Scholar 

  8. Smadja NV, Bastard C, Brigaudeau C, Leroux D, Fruchart C (2001) Hypodiploidy is a major prognostic factor in multiple myeloma. Blood 98:2229–2238

    Article  PubMed  CAS  Google Scholar 

  9. Lai JL, Michaux L, Dastugue N, Vasseur F, Daudignon A, Facon T et al (1998) Cytogenetics in multiple myeloma: a multicenter study of 24 patients with t(11;14)(q13;q32) or its variant. Cancer Genet Cytogenet 104:133–138

    Article  PubMed  CAS  Google Scholar 

Download references

Conflicts of interest

The authors declare that they have no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Eul-Ju Seo.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ji, M., Jang, S., Lee, JH. et al. Double-hit myeloma with IGH/MYC and IGH/CCND1 translocations. Ann Hematol 92, 1129–1131 (2013). https://doi.org/10.1007/s00277-012-1668-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-012-1668-y

Keywords

Navigation